Impact of a guaranteed access program to imatinib on the survival of patients with chronic myeloid leukemia.
Barranco G, Vidal I, Gama D, Martínez C, Acosta B, Ramos C, Martínez E, Zazueta J, Olarte I, Martínez A, Cervera E, Mendoza I, Arcos D, Cruz J.
Barranco G, et al. Among authors: acosta b.
Cancer Causes Control. 2024 Dec;35(12):1557-1563. doi: 10.1007/s10552-024-01912-1. Epub 2024 Sep 10.
Cancer Causes Control. 2024.
PMID: 39254912